Impact of serum lipoprotein(a) on endothelium-dependent coronary vasomotor response assessed by intracoronary acetylcholine provocation

被引:6
作者
Mashaly, Ahmed [1 ,3 ]
Rha, Seung-Woon [1 ]
Choi, Byoung Geol [2 ]
Baek, Man Jong [1 ]
Ryu, Yang Gi [1 ]
Choi, Se Yeon [2 ]
Byun, Jae Kyeong [2 ]
Abdelshafi, Kareem [1 ]
Park, Yoonjee [1 ]
Jang, Won Young [1 ]
Woohyeun, Kim [1 ]
Park, Eun Jin [1 ]
Choi, Jah Yeon [1 ]
Na, Jin Oh [1 ]
Choi, Cheol Ung [1 ]
Lim, Hong Euy [1 ]
Kim, Eung Ju [1 ]
Park, Chang Gyu [1 ]
Seo, Hong Seog [1 ]
机构
[1] Korea Univ, Dept Internal Med, Div Cardiol, Guro Hosp, Seoul, South Korea
[2] Korea Univ, Dept Med, Grad Sch, Seoul, South Korea
[3] Tanta Univ, Dept Cardiol, Med Sch, Tanta, Egypt
关键词
coronary artery spasm; endothelial dysfunction; intracoronary acetylcholine provocation test; lipoprotein(a); PERIPHERAL ARTERY-DISEASE; LONG-TERM OUTCOMES; HEART-DISEASE; CARDIOVASCULAR-DISEASE; PLASMA LIPOPROTEIN(A); RISK; SPASM; APOLIPOPROTEIN(A); RESTENOSIS; GUIDELINES;
D O I
10.1097/MCA.0000000000000642
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundLipoprotein(a) [Lp(a)] is an independent risk factor for atherosclerotic vascular disease. However, there are limited data regarding the impact of Lp(a) levels on the incidence and severity of endothelium-dependent coronary vasomotor response.Patients and methodsA total of 2416 patients without significant coronary artery lesion (<50% stenosis) by coronary angiography and underwent acetylcholine (ACh) provocation test were enrolled and categorized according to their serum Lp(a) level into four quartile groups: less than 6.70, 6.70-13.30, 13.30-26.27, and more than 26.27mg/dl. The aim of this study is to estimate the incidence and severity of endothelium-dependent positive ACh provocation test in each group; moreover, to access the incidence of major adverse cardiovascular events, the composite of total death, myocardial infarction, and de novo percutaneous coronary intervention were compared between the four groups up to 5 years.ResultsThe group with higher Lp(a) had a higher incidence of coronary heart disease, myocardial infarction, and peripheral arterial disease history. However, there was no difference among the four groups as regards the incidence of positive ACh provocation test, spasm severity, spasm extent, and location. However, at up to 5 years of clinical follow-up, the higher-Lp(a) group showed higher total death, de novo percutaneous coronary intervention, recurrent angina, and total major adverse cardiovascular events compared with the lower-Lp(a) groups.ConclusionIn our study, there was no relationship between the elevated Lp(a) level and the vasospastic response to the intracoronary ACh provocation test; however, higher Lp(a) levels were associated with poor clinical outcomes up to 5 years.
引用
收藏
页码:516 / 525
页数:10
相关论文
共 42 条
[1]   Lipoprotein(a) levels and risk of future coronary heart disease [J].
Bennet, Anna ;
Di Angelantonio, Ernanuele ;
Erqou, Sebhat ;
Eiriksdottir, Gudny ;
Sigurdsson, Gunnar ;
Woodward, Mark ;
Rumley, Ann ;
Lowe, Gordon D. O. ;
Danesh, John ;
Gudnason, Vilmundur .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (06) :598-608
[2]   Role of lipoprotein(a) in cardiovascular disease - Current and future perspectives [J].
Berglund, Lars ;
Anuurad, Erdembileg .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (02) :132-134
[3]   2016 ESC/EAS Guidelines for the Management of Dyslipidaemias [J].
Catapano, Alberico L. ;
Graham, Ian ;
De Backer, Guy ;
Wiklund, Olov ;
Chapman, M. John ;
Drexel, Heinz ;
Hoes, Arno W. ;
Jennings, Catriona S. ;
Landmesser, Ulf ;
Pedersen, Terje R. ;
Reiner, Zeljko ;
Riccardi, Gabriele ;
Taskinen, Marja-Riita ;
Tokgozoglu, Lale ;
Monique, W. M. ;
Verschuren, W. M. Monique ;
Vlachopoulos, Charalambos ;
Wood, David A. ;
Luis Zamorano, Jose .
EUROPEAN HEART JOURNAL, 2016, 37 (39) :2999-+
[4]   Impact of hypertension on coronary artery spasm as assessed with intracoronary acetylcholine provocation test [J].
Chen, K-Y ;
Rha, S-W ;
Li, Y-J ;
Poddar, K. L. ;
Jin, Z. ;
Minami, Y. ;
Saito, S. ;
Park, J. H. ;
Na, J. O. ;
Choi, C. U. ;
Lim, H. E. ;
Kim, J. W. ;
Kim, E. J. ;
Park, C. G. ;
Seo, H. S. ;
Oh, D. J. .
JOURNAL OF HUMAN HYPERTENSION, 2010, 24 (02) :77-85
[5]   Lipoprotein (a) and its relationship to risk factors and severity of atherosclerotic peripheral vascular disease [J].
Cheng, SWK ;
Ting, ACW ;
Wong, J .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 1997, 14 (01) :17-23
[6]   Lipoprotein(a) and coronary heart disease - Meta-analysis of prospective studies [J].
Danesh, J ;
Collins, R ;
Peto, R .
CIRCULATION, 2000, 102 (10) :1082-1085
[7]  
Danik JS, 2006, JAMA-J AM MED ASSOC, V296, P1363, DOI 10.1001/jama.296.11.1363
[8]  
Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063
[9]   The relationship between Lp(a) and CVD outcomes: a systematic review [J].
Forbes, Carol A. ;
Quek, Ruben G. W. ;
Deshpande, Sohan ;
Worthy, Gill ;
Wolff, Robert ;
Stirk, Lisa ;
Kleijnen, Jos ;
Gandra, Shravanthi R. ;
Djedjos, Stephen ;
Wong, Nathan D. .
LIPIDS IN HEALTH AND DISEASE, 2016, 15
[10]   Race Is a Key Variable in Assigning Lipoprotein(a) Cutoff Values for Coronary Heart Disease Risk Assessment The Multi-Ethnic Study of Atherosclerosis [J].
Guan, Weihua ;
Cao, Jing ;
Steffen, Brian T. ;
Post, Wendy S. ;
Stein, James H. ;
Tattersall, Mathew C. ;
Kaufman, Joel D. ;
McConnell, Joseph P. ;
Hoefner, Daniel M. ;
Warnick, Russell ;
Tsai, Michael Y. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2015, 35 (04) :996-1001